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~ Right Ventdculer Load Transcriptionally Activates 
the F1-ATP Synthese ~obunt t  In Vlvo and a 
Cis-Reglon of  Its Gene Is Inducible by Hypertrophic 
Stimuli In Cardlocytas " 
Tenenca X. O'Bden, Donald R. Menick, Mary S, Rackley, John D. Rozich, 
Paul J. McDermott, George Cooper W. VAMC & Medical University of South 
Carolina, Charleston, SC 
The mltochonddal F1-ATP synthase .8-sUbunlt (p-ATPese) is a key nuclear- 
encoded gene that must be precisely coordinated in oxidative phosphoryla- 
tion. Because of the hearra acute ATP requirements during hemod';namlc 
stress, and at least the initial ~.tnges of hear failure, 8-ATPase gene expres- 
sion was examined in an acute in vivo feline right ventdcular pressure over- 
load model and two in vitro models using neonatal rat cardiocytas timulated 
with either electrical pacing or phenyleph~'lne (PIE). ~-ATPase mRNA levels 
upregulatad rapidly, after 1 and 4 hr of acute load in vivo and by 2 hr reaching 
an equilfbdum between 12-I 8 hr with PE and 24-48 hr w~h electricaJ ~cin~. 
To investigate regulation, the polymerase chain reaction was used to isolate 
several gene fragments, including two -392 bp and -1522 t~ upstream of 
transcription initiation. P~ter subctot~ng into a lucltaresa repealer vector 
transiently co-trensf~cting with controls into neonatal rat cardiocyfas i;stng 
calcium phosphate precip~etton, these cells were atimulefed with PE or elec- 
trical pacing for 48 hr. l"~e -1522 construct demoeslratsd reporter activity 
which was inducible 20~/o by both PE and pacing, supporting the presence 
of important regulalonj c/s elements. The 392 bp promoter construct, which 
included elements known to be constitutively active in non-cardiac ells, was 
active but not indudbie, indicating a tack ot rote in cardiac inducibility. West- 
em blotting showed ,8-ATPase protein levels increasing pmpor~onata~/to 
lo~reeses in total protein. Therefore, the in vivo upregulalion of ,8-ATPasa to 
load is, In vitro to two disparate hypertrophic stimuli, at least portly transcrip- 
tlunal and includes the demonstration for the first time of inducibility of the 5' 
region. 
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~ Time-Dependent Changes in Gene ExpresMon in 
Myocytes From the Non-Infarcted Myoe, ardlum of  
Rats With Evolving Head Failure 
Ping Yue, Cadin S. Long, Paul C. Simpson, Wendy Hartogeesis, R 
David Foduln, Barry M. Massle, VAMC and Univ. of Ca, San Francia~, CA 
Fetal gane expression reemerges In pressure-ovedoed models of heart fail- 
ure, but less information is available in post-infamtion models. Therefore, 
we examined ,8 and aPmyosin heavy chains (MHC), skeletal ¢-astin (sACT) 
and sarcoplasmlc reticulum ATPase (SERCA2) mRNAs in myocytos isolated 
from the non-infarCted myocardium in rats t day, 1 wk and 6 wks following 
left coronary adery ligatlon (n = 6 for each time point) and sham-operated 
controls (n = 4 each). Only rats with large infarctions by ECG criteria and 
LVEDP > 15 mmHg were included. After hemodynamic measurements, mp 
ocytes were enzymatically isolated and cell volumes were determined using 
a Coulter muitisizer. RNA was extracted from LV myoaytes, and mRNA lev- 
els were determined by Northern and RNase protection assays. MI rats had 
hemodynamtc evidence of hear failure at each time ~lnt (elevated LVEDP 
and diminished P/dt) and significant LV myocyte hypertrophy at 6 wks (my- 
oayte volumes: 41.5 ± 0.9 vs 29.5 ± 2.6 x lIP pn~, p < 0.03). In rats 
with hear failure, compared to controls at the same time paint, sACT mRNA 
increased by 1.42, 1.53 and 134-fold at I day I wk and 6 wks, respeddvely 
(p = 0.05, < 0.05 and < 0.01). ,8-MHC mRNA was elevated at I and 6 wks 
(1,66 and 1.95 fold {p = 0.05 and < 0.01, respectively), and =-MHC message 
was 48% lower in heart failure rats at 6 wks (p < 0.001). SERCA2 mRNA was 
not affected at any time paint. Thus, dudng the remndgling procesa post-MI, 
changes in myocyte gene expression may occur as early as 24 hours. By 6 
wks, non-lnfarctad myocytes exhibit hypertrophy and changes in contractile 
protein expression similar to those observed in pressure-overload models 
of LVH and head failure. In contrast to the hypertrophy model I~owever, in 
past-infarction myocytes, SERCA2 expression is not repressed. 
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~ Beneficial Hemodynamle Actions of  Serectlve 
Endothelln-1 (Er.1) Blockade in Experimental Heart 
Failure 
Gordon W. Moe, Ana A~bomaz, Robert J, Howard, Duncan Stowed. 
University of Toronto, Toronto, ON, Canada 
Both plasma ET-1 and atrial netriuretio paptide (ANP) levels are elevated 
in hear failure (HF). To clarify the biologic role of endogenous ET-1 and its 
Interaction with ANP, we administered a specitlc ETA receptor alltagonigt 
FR-139137 (10 ug/kg/min IV for 45 minutes) to 7 dogs at baseline (B) and 
after induclion of HF by 4 weeks of rapid RV pacing. Data shown are 
and pcol~l SD (SDp) from ANOVA for HR (beats/mln); MAP (ram Fig); CO, 
(I/rain); systemic ~ ~ulmonic vascular resistance (SVR, PVR, units) at 
control (CTL) and 45 minutes of infusion (45 rain), at B and HE 
HR MAP CO SVR PVR 
B HF B HF B HF B HF B HF 
C]'l. 58 1471" 107 104 2.3 1.71" 45 5at 2,5 6.3 t 
45 min 76* 144 112 101 2,9" 2.1" 37* 43- 1,9" 4,7" 
SOp 9 25 18 11 0.5 0,4 11 9 0,7 1.5 
"p < O.OS w. CTL. tp < O.O5 vs. B 
HFwas assoclated with reduced CO and increased HR, SVR and PVR. FR- 
139137 increased CO and decreased SVR and PVR by similar propolons 
at B and HR HR was increased only at B. LV dp/dt and mean PA pressure 
were net changed by FR-139137 at B or HF. Plasma ANP (273 ± 88 at HF 
vs. 32 :~ 9 pg/ml at B, p < 0.01) and ET-1 levels (19 ± 4 at PIF vs. 12:1: 
3 p~ml at S, p < 0.05) were also not alts;ed by FR-139137 at B or HF, 
These data indicate that endogenous ET-1 conth'butes to the maintenance 
of SVR and PVR in normal condition and heightened SVR and PVR (n HE 
Fudhen~ore, our data do not support he role for the ETA receptor in the 
negative feedback regulation of ET-1 level and stimulation of ANP secretion 
in vivo in this model. 
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~ 11ssue Endothelin-1 lET-l) Profile in Experimental 
Heart Failure 
P. Cemasek, D J..Stewart, H. Gosselin, J. L. Rouleau. Me, Gill University, 
MontreN Heart It, ~ :itute, Montreal, QC; Universily of Toronto, St. Michae/~ 
Ho~o#al, T~onto ON, Canada 
Plasma levels of El-1 increase in severe heart failure (HF), however, little is 
known about local ~sue expression of ET-1 in the heart and other organs. 
We measured ET-I in the head, lung, k i~  and liver of 26 rats with vadous 
degrees of HF, 5 weeks after coronary ligation. The rats were divided ~n 3 
groups according to the size ol infarction scar. Gfl, < 55 mn~; Gdt, 90-130 
ram=; Gdif, > 160 mm 2. ET-t. Tissue levels were as follows (mean :E SEM, 
"p < 0.05): 
Gr (n) Vent. 
(Wing) 
C (7) 55 4-10 
I (111 544-10 
It ('~ 654- ~,,. 
Ul (8) 162 4-L"  
Atrial Pulm Corlex Pap~. 
(p~mg) (pg/mg pint) (p~'mg) (Wrng) 
N/D 29±2 0.74-11 2.1~0.1 
G :E0.1 97:1:2 0.6 ~0.1 5.5 :~ 0.7" 
" ]±0.05 31 :E2 0.6:t:0,1 5.9~0.6" 
i A-k 0.9" 51:t. 1" 1.14-0.1" 6.1~: 0.6" 
mean :i: SEM, "p ~ u.O5 
Compared with 7 control rats (G), ventfi~lar, atrial, pulmonary and renal 
cortical ET-1 was significantly increased on,'y in Gdll, whereas, in the renal 
papillae all 3 groups exhibited an increase. In contrasL them was no increase 
in the liver content of ET-1 in Gdll vs. C (196 ± 12 and t92 ± 8 fg/mg, map). 
Moreover, both ventdcutar and pulmonary ET-1 were significantly correlated 
w/th left vanti'/culer end diasto//c pm~sure (r : 0.65 and 0.74, rasp). We 
conclude that heart failure is associated with an increase in tissue levels 
of ET-1, in particular in the renal pa~'llae. Increases in ET-1 in the lung 
and ventricles In severe HF may contribute to ~)ulmonary hypertension or 
be involved in remodeling in response to the critical impairment of central 
he~dy.am~. 
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~ T h e  Impact of Fatal Echocardiography on the 
Diagnosis of  Congenital Heart Defects: A 
Populctinn Based Study, Atlanta, 1990-1994 
Eduardo Montana, Muin Khoury, Kenneth Dooley, Shire Sham~, 
Pradip Dher, Janet Cregan, Kenneth Lynch, Derek Fyfe. Centers for 
Disease Centre/and Prevention and Fmory Univemi~ School of Medicine, 
At/ant& Georgia 
Them are few paputatior~based data on the current impact of fetal echecar- 
diography (FE) on the diagnosis, btrth prevalence rates, and overall survival 
